Abiopharma

🔍 Pearson Gregory Carl (Executive)

Company: Post Holdings, Inc. (POST)

Report Date: 2026-04-05

Detailed Transactions and Holdings:

• Acquired 5,914 shares of Common Stock (Direct)
  Date: 2026-04-05 | Code: A | equity_swap_involved: 0 | shares_owned_after: 5,914.00 | transaction_form_type: 4 | Footnotes: F1
• Acquired 2,571 shares of Common Stock (Direct)
  Date: 2026-04-05 | Code: A | equity_swap_involved: 0 | shares_owned_after: 8,485.00 | transaction_form_type: 4 | Footnotes: F2

Footnotes:

• F1: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Post Holdings, Inc. ("Post") common stock. The RSUs were granted under the Post Holdings, Inc. Amended and Restated 2021 Long-Term Incentive Plan (the "A&R 2021 LTIP") in a transaction exempt under Rule 16b-3 and vest in equal annual increments over three years, subject to the terms of the award agreement.
• F2: Each RSU represents a contingent right to receive one share of Post common stock. The RSUs were granted under the A&R 2021 LTIP in a transaction exempt under Rule 16b-3 and vest in full on the second anniversary of the grant date, subject to the terms of the award agreement.